Virtus ETF Advisers’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,770
| Closed | -$63.6K | – | 623 |
|
|
2024
Q4 | $63.6K | Buy |
5,770
+514
| +10% | +$5.67K | 0.03% | 430 |
|
|
2024
Q3 | $64.6K | Buy |
5,256
+89
| +2% | +$1.09K | 0.03% | 435 |
|
|
2024
Q2 | $69.8K | Buy |
+5,167
| New | +$69.8K | 0.03% | 430 |
|
|
2023
Q4 | – | Sell |
-7,893
| Closed | -$31.1K | – | 459 |
|
|
2023
Q3 | $31.1K | Sell |
7,893
-785
| -9% | -$3.09K | 0.02% | 427 |
|
|
2023
Q2 | $92.2K | Sell |
8,678
-3,400
| -28% | -$36.1K | 0.05% | 412 |
|
|
2023
Q1 | $101K | Sell |
12,078
-4,637
| -28% | -$38.6K | 0.06% | 337 |
|
|
2022
Q4 | $154K | Buy |
16,715
+6,745
| +68% | +$62.3K | 0.08% | 339 |
|
|
2022
Q3 | $128K | Buy |
9,970
+75
| +0.8% | +$963 | 0.05% | 383 |
|
|
2022
Q2 | $131K | Buy |
9,895
+1,336
| +16% | +$17.7K | 0.05% | 349 |
|
|
2022
Q1 | $180K | Sell |
8,559
-511
| -6% | -$10.7K | 0.08% | 206 |
|
|
2021
Q4 | $218K | Buy |
9,070
+3,568
| +65% | +$85.8K | 0.08% | 196 |
|
|
2021
Q3 | $140K | Sell |
5,502
-284
| -5% | -$7.23K | 0.06% | 353 |
|
|
2021
Q2 | $195K | Buy |
5,786
+425
| +8% | +$14.3K | 0.08% | 359 |
|
|
2021
Q1 | $208K | Buy |
5,361
+97
| +2% | +$3.76K | 0.09% | 323 |
|
|
2020
Q4 | $326K | Buy |
+5,264
| New | +$326K | 0.14% | 188 |
|